Answers are grounded in this paper and cite their sources.
Clinical course in schizophrenia is often characterized by recurrent relapses, which are associated with adverse outcomes. Immune system abnormalities, including inflammation, have been one of the more enduring findings in the field, and several recent findings suggest that relapse in some patients with schizophrenia may be an immune mediated effect.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: